What is the difference between Deslorelin and GHRP-2?

Deslorelin: Potent GnRH super agonist approximately 100× more potent than native GnRH. Used in veterinary medicine for estrus suppression and in human medicine for precocious puberty treatment. In research protocols, used for pituitary desensitization to reset the HPG axis or induce controlled medical suppression of sex hormone production. GHRP-2: GHRP-2 is a synthetic hexapeptide that acts as a ghrelin mimetic, stimulating the pituitary gland to secrete growth hormone (GH). It is one of the most potent GH secretagogues studied, producing stronger GH pulses than GHRP-6 with comparatively less appetite stimulation. Both are in the Performance & Growth Hormone category but differ in mechanism, dosing, and research evidence — see the full comparison.

Can you take Deslorelin and GHRP-2 together?

There is no specific, well-documented interaction rule for combining Deslorelin and GHRP-2 in the aggregated research reviewed. Combining peptides should only be considered under professional supervision. This is not medical advice.

Which is better researched, Deslorelin or GHRP-2?

Deslorelin is currently research-stage and GHRP-2 is preclinical only. "Better researched" depends on your research goal — review each profile's cited sources.

Performance & Growth Hormone · Comparison

Deslorelin vs GHRP-2

A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

Deslorelin

Research-stage

Potent GnRH super agonist approximately 100× more potent than native GnRH. Used in veterinary medicine for estrus suppression and in human medicine for precocious puberty treatment. In research protocols, used for pituitary desensitization to reset the HPG axis or induce controlled medical suppression of sex hormone production.

Full profile

GHRP-2

Preclinical only

GHRP-2 is a synthetic hexapeptide that acts as a ghrelin mimetic, stimulating the pituitary gland to secrete growth hormone (GH). It is one of the most potent GH secretagogues studied, producing stronger GH pulses than GHRP-6 with comparatively less appetite stimulation.

Full profile

	Deslorelin	GHRP-2
Category	Performance & Growth Hormone	Performance & Growth Hormone
Also known as	SuvaPryn, Ovuplant, D-His6-Pro9-Et-GnRH	Growth Hormone Releasing Peptide-2, Pralmorelin, KP 102
Evidence	Research-stage	Preclinical only
Dosing range	50mcg–200mcg mcg, Daily SC for continuous suppression; single or short course for pituitary reset	100mcg–300mcg mcg, 1–3 times daily, on an empty stomach
Administration	Subcutaneous implant (veterinary), Subcutaneous injection	Subcutaneous injection, Intramuscular injection
Key side effects	Hot flashes, Bone density loss (prolonged suppression), Suppression of testosterone or estrogen, Mood changes, irritability	Increased hunger (less than GHRP-6), Elevated cortisol and prolactin at high doses, Water retention, Injection site irritation
Cited sources	2 references	3 references

Key differences

Evidence level differs: Deslorelin is research-stage, while GHRP-2 is preclinical only.
Administration: Deslorelin — Subcutaneous implant (veterinary), Subcutaneous injection; GHRP-2 — Subcutaneous injection, Intramuscular injection.
Frequency: Deslorelin is typically Daily SC for continuous suppression; single or short course for pituitary reset; GHRP-2 is 1–3 times daily, on an empty stomach.
Research depth: this profile cites 2 sources for Deslorelin vs 3 for GHRP-2.

How each works

Deslorelin

Deslorelin produces a robust initial LH/FSH surge (flare effect) followed by profound, sustained pituitary desensitization with continued exposure. This biphasic response is consistent across all high-affinity GnRH super agonists. The flare phase is exploited for reproductive timing in veterinary medicine; the desensitization phase creates the clinical suppression used in precocious puberty and research HPG axis reset protocols.

GHRP-2

GHRP-2 has been extensively studied in both animal and human subjects. Clinical trials have demonstrated significant GH elevation in healthy adults, with a peak GH pulse occurring 15–30 minutes post-injection. Studies show it increases IGF-1 levels with chronic use and may have mild cardioprotective properties. Unlike GHRP-6, it has a lower propensity to stimulate cortisol and prolactin at standard doses.

Read the full Deslorelin profile Read the full GHRP-2 profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.